Small trial: engineered bone-marrow cell infusion sharply cuts osteoporosis fractures
Researchers gave ten older women with severe osteoporosis a single infusion of their own bone-marrow cells, which had been lab-modified to better home in on bone tissue. Before the treatment the women fractured bones roughly every one to two years; afterward, low-impact fractures dropped to about once per decade, according to a study published in Cell.